Right now, there are simply not that many solid options for treating people who have mesothelioma. However, a recent study may have opened up some new doors, as it explored the use of bevacizumab and found good results.
Bevacizumab is often sold under the name Avastin, and it's made by Genentech/Roche. It has been used in the past with lung cancer, and it has been shown to work. The study experimented with using it and a standard chemotherapy regimen when doctors were trying to treat mesothelioma that was in its advanced stages.